PRA Health Sciences Inc

PRA Health Sciences — Q2 2015 Earnings Presentation

17 slides from PRA Health Sciences's earnings presentation, Jul 27, 2015

  1. Slide 1: Q2 2015 Earnings

    Q2 2015 Earnings July 27, 2015

  2. Slide 2: Forward Looking Statements and Use of Non-GAAP Financial Measures

    Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements that reflect, among other things, the Company’s current expectations and anticipated results of operations, all of which are subject to known and unknown risks, uncertainties and o

  3. Slide 3: Q2 2015 Highlights

    Q2 2015 Highlights ($ in millions) $337 million of service revenue; 12% constant currency growth $61 million of Adjusted EBITDA; 35% growth compared to prior year Adjusted Net Income per share of $0.47; 37% growth compared to prior year Q2 2015 Q2 2014 % Change Service Revenue $336.5 $311.4 8.1% EBI

  4. Slide 4: Trailing Quarterly Performance

    Trailing Quarterly Performance Gross Profit ($M) Adjusted EBITDA Margin (%) Service Revenue ($M) Adjusted EBITDA ($M) $94.0 $96.3 $98.2 $104.5 $109.1 $113.2 $116.9 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 11.8% 12.7% 14.6% 14.7% 15.6% 16.8% 18.2% 11% 12% 13% 14% 15% 16% 17% 18% 19% Q4

  5. Slide 5: Backlog and New Business Awards

    Backlog and New Business Awards Ending Backlog ($M) Backlog Conversion % Net Book-to-Bill Net New Business Awards ($M) 1.12 1.13 1.19 1.19 1.20 1.20 1.21 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q1 2015 Q2 2015 $201.9 $351.3 $371.9 $382.1 $388.4 $398.0 $407.8 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Q

  6. Slide 6: Debt Structure

    Debt Structure Weighted Average ($ in millions) June 30, September 30, December 31, March 31, June 30, Interest Maturity 2014 2014 2014 2015 2015 Rate Date Senior debt: First Lien 883.3 $ 881.1 $ 729.0 $ 714.0 $ 699.0 $ 4.50% September 23, 2020 Senior Notes 375.0 375.0 225.0 225.0 225.0 9.50% Octobe

  7. Slide 7: Full Year 2015 Guidance

    Full Year 2015 Guidance Previous Guidance Revised Guidance Expected Service Revenue $1.34B - $1.39B $1.34B - $1.39B Diluted GAAP Net Income per Share $0.70 - $0.80 $0.80 - $0.90 Diluted Adjusted Net Income per Share $1.62 – $1.72 $1.75 - $1.85 Annual Effective Income Tax Rate 30% 30% Revised guidanc

  8. Slide 8: arra01s

    arra01s PRAHEALTHSCIENCES * ies ‘ i

  9. Slide 9: Q2 and YTD 2015 Financial Results

    Q2 and YTD 2015 Financial Results ($ in millions) 2015 2014 % Change 2015 2014 % Change Service Revenue 336.5 $ 311.4 $ 8.1% 668.5 $ 622.8 $ 7.3% EBITDA 52.7 $ 36.2 $ 45.6% 112.5 $ 66.2 $ 69.9% Adjusted EBITDA 61.3 $ 45.5 $ 34.9% 117.1 $ 85.2 $ 37.4% Adjusted EBITDA Margin 18.2% 14.6% 17.5% 13.7% Op

  10. Slide 10: Trailing Quarterly Performance

    Trailing Quarterly Performance Q2 15 v ($ in millions) Q2 14 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Change Service revenue 166.5 $ 179.5 $ 188.1 $ 298.8 $ 832.9 $ 311.4 $ 311.3 $ 320.1 $ 323.8 $ 1,266.6 $ 332.0 $ 336.5 $ 8.1% % growth Y-o-Y 13.0% 22.2% 27.9% 91.7% 39.5% 87.0% 73.4% 70.2% 8.4% 52.1% 6

  11. Slide 11: Backlog and New Business Awards

    Backlog and New Business Awards Q2 15 v ($ in millions) Q2 14 % Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Change Beginning Backlog 1,382.8 $ 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,382.8 $ 1,939.7 $ 1,987.3 $ 2,044.8 $ 2,091.5 $ 1,939.7 $ 2,141.1 $ 2,185.3 $ Ending Backlog 1,421.2 $ 1,444.2 $ 1,465.6 $ 1,939.7 $

  12. Slide 12: Reconciliation of GAAP EBITDA to Adjusted EBITDA

    Reconciliation of GAAP EBITDA to Adjusted EBITDA For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 2015 2014 Net income (loss) 12.4 $ (4.1) $ 29.6 $ (14.1) $ Depreciation and amortiz

  13. Slide 13: Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income

    Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions, except per share data) 2015 2014 2015 2014 Net income (loss) 12.4 $ (4.1) $ 29

  14. Slide 14: Reconciliation of GAAP Income from Operations to Adjusted Income from Operations

    Reconciliation of GAAP Income from Operations to Adjusted Income from Operations For further information regarding the reconciliation of non-GAAP measures to their corresponding GAAP equivalent please see our press release ($ in millions) 2015 2014 2015 2014 Income from operations 38.3 $ 17.4 $ 71.3

  15. Slide 15: Geographic Breakdown

    Geographic Breakdown Region YTD 2015 YTD 2014 US/Canada 407,725 368,239 Europe/Africa 200,173 202,863 Latin America 27,269 26,368 Asia/Pacific 33,318 25,304 Grand Total 668,486 622,774 Region Q2 2015 Q2 2014 US/Canada 205,758 186,142 Europe/Africa 99,163 99,792 Latin America 13,823 12,465 Asia/Pacif

  16. Slide 16: Days Sales Outstanding

    Days Sales Outstanding ($ in millions) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Accounts Receivable, net 136.9 $ 157.4 $ 141.2 $ 232.6 $ 246.0 $ 241.9 $ 236.1 $ 233.3 $ 239.6 $ 281.4 $ Unbilled Services 63.1 56.2 58.3 62.3 102.3 98.0 113.2 105.5 132.8 115.2 Total Accounts Receivable and Unbilled Services 200.0

  17. Slide 17: PRA Health Sciences: The Future of Clinical Development

    Prahealthsciences The Future of clinical development

PRA Health Sciences — Q2 2015 Earnings Presentation on 6ix